These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28239021)

  • 1. Needs Assessment of HCV-Infected Individuals Experiencing Homelessness and Implications.
    Beiser M; Leon C; Gaeta JM
    J Health Care Poor Underserved; 2017; 28(1):596-606. PubMed ID: 28239021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.
    Beiser ME; Smith K; Ingemi M; Mulligan E; Baggett TP
    Int J Drug Policy; 2019 Oct; 72():129-137. PubMed ID: 30962036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative Approaches to Engaging Homeless and Marginally Housed Patients in Care: a Case Study of Hepatitis C.
    Conti J; Dryden E; Fincke BG; Dunlap S; McInnes DK
    J Gen Intern Med; 2023 Jan; 38(1):156-164. PubMed ID: 35879538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Rogal SS; McCarthy R; Reid A; Rodriguez KL; Calgaro L; Patel K; Daley M; Jonassaint NL; Zickmund SL
    Dig Dis Sci; 2017 Aug; 62(8):1933-1943. PubMed ID: 28523579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons.
    Thompson VV; Ragland KE; Hall CS; Morgan M; Bangsberg DR
    AIDS; 2005 Oct; 19 Suppl 3():S208-14. PubMed ID: 16251820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Treatment Cascade in a Federally Qualified Health Center.
    Hachey DM; Holmes JT; Aubuchon-Endsley NL
    J Community Health; 2020 Apr; 45(2):264-268. PubMed ID: 31512110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budgetary impact analysis of a primary care-based hepatitis C treatment program: Effects of 340B Drug Pricing Program.
    Jones EA; Linas BP; Truong V; Burgess JF; Lasser KE
    PLoS One; 2019; 14(3):e0213745. PubMed ID: 30870475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Dedicated Hostel-based Liver Service for Vulnerable/Homeless Adults: Response to: Needs Assessment of HCV-Infected Individuals Experiencing Homelessness and Implications.
    Hashim A; Verma S
    J Health Care Poor Underserved; 2017; 28(4):xi-xii. PubMed ID: 29176091
    [No Abstract]   [Full Text] [Related]  

  • 9. A qualitative investigation of organizational challenges and facilitators to screening individuals experiencing homelessness for hepatitis C virus (HCV) in Houston, Texas.
    Celeste-Villalvir A; Wilkerson JM; Markham C; Rodriguez L; Schick V
    PLoS One; 2022; 17(8):e0273302. PubMed ID: 35994438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From peer-based to peer-led: redefining the role of peers across the hepatitis C care pathway: HepCare Europe.
    Surey J; Menezes D; Francis M; Gibbons J; Sultan B; Miah A; Abubakar I; Story A
    J Antimicrob Chemother; 2019 Nov; 74(Suppl 5):v17-v23. PubMed ID: 31782500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
    Masson CL; Fokuo JK; Anderson A; Powell J; Zevin B; Bush D; Khalili M
    BMC Infect Dis; 2020 May; 20(1):386. PubMed ID: 32471376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
    Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ
    J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-Based Assessment and Treatment of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst People Who Are Homeless: A Systematic Review and Meta-Analysis.
    Hashim A; Macken L; Jones A; McGeer M; Aithal G; Verma S
    Int J Drug Policy; 2021 Oct; 96():103342. PubMed ID: 34210551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV treatment barriers among HIV/HCV co-infected patients in the US: a qualitative study to understand low uptake among marginalized populations in the DAA era.
    Nápoles TM; Batchelder AW; Lin A; Moran L; Johnson MO; Shumway M; Luetkemeyer AF; Peters MG; Eagen KV; Riley ED
    J Public Health (Oxf); 2019 Dec; 41(4):e283-e289. PubMed ID: 31044248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engaging the Community in Designing a Hepatitis C Virus Treatment Program for Adults Experiencing Homelessness.
    Nyamathi AM; Wall SA; Yadav K; Shin SS; Chang A; Arce N; Cuellar H; Fernando S; White K; Gelberg L; Salem BE
    Qual Health Res; 2021 Sep; 31(11):2069-2083. PubMed ID: 34189974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Perspectives of Unhoused Adults and Providers Across the HCV Care Continuum.
    Salem BE; Almeida H; Wall SA; Yadav K; Chang AH; Gelberg L; Nyamathi A
    Clin Nurs Res; 2024 Sep; 33(7):519-529. PubMed ID: 39246038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response.
    Lubega S; Agbim U; Surjadi M; Mahoney M; Khalili M
    Liver Int; 2013 Aug; 33(7):999-1007. PubMed ID: 23509897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans.
    Beck KR; Kim NJ; Khalili M
    Ann Hepatol; 2018; 17(3):413-418. PubMed ID: 29735789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A financial incentive program to improve appointment attendance at a safety-net hospital-based primary care hepatitis C treatment program.
    Lee KS; Quintiliani L; Heinz A; Johnson NL; Xuan Z; Truong V; Lasser KE
    PLoS One; 2020; 15(2):e0228767. PubMed ID: 32045447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.